Inmune Bio, Inc. Quarterly Return On Equity in % from Q3 2022 to Q2 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Inmune Bio, Inc. quarterly/annual Return On Equity history and growth rate from Q3 2022 to Q2 2023.
  • Inmune Bio, Inc. Return On Equity for the quarter ending June 30, 2023 was -46.3 %.
Return On Equity, Quarterly (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2023 -46.3 Apr 1, 2023 Jun 30, 2023
Q1 2023 -43.3 Jan 1, 2023 Mar 31, 2023
Q4 2022 -40.5 Oct 1, 2022 Dec 31, 2022
Q3 2022 -43 Jul 1, 2022 Sep 30, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.